A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers
NCT00262210
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG:
Cyclophosphamide Epirubicin Etoposide Prednisolone
Sponsor
National Health Research Institutes, Taiwan